Search: WFRF:(Nilsson Kerstin 1953 )
> (2015-2019) >
Enhanced Recovery a...
Enhanced Recovery after Surgery Protocol in Abdominal Hysterectomies for Malignant versus Benign Disease
-
- Wijk, Lena, 1971- (author)
- Örebro universitet,Institutionen för medicinska vetenskaper,Department of Obstetrics and Gynecology, Örebro University Hospital, Örebro, Sweden
-
- Franzén, Karin, 1958- (author)
- Örebro universitet,Institutionen för medicinska vetenskaper,Department of Obstetrics and Gynecology, Örebro University Hospital, Örebro, Sweden
-
- Ljungqvist, Olle, 1954- (author)
- Karolinska Institutet,Örebro universitet,Institutionen för medicinska vetenskaper,Department of Surgery, Örebro University Hospital, Örebro, Sweden
-
show more...
-
- Nilsson, Kerstin, 1953- (author)
- Örebro universitet,Institutionen för medicinska vetenskaper,Department of Obstetrics and Gynecology, Örebro University Hospital, Örebro, Sweden
-
show less...
-
(creator_code:org_t)
- 2016-01-23
- 2016
- English.
-
In: Gynecologic and Obstetric Investigation. - Basel : S. Karger. - 0378-7346 .- 1423-002X. ; 81:5, s. 461-467
- Related links:
-
https://urn.kb.se/re...
-
show more...
-
https://doi.org/10.1...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- Background: The enhanced recovery after surgery (ERAS) protocol combines unimodal evidence-based interventions aiming to enhance recovery after surgery and reduce length of stay (LOS). We introduced an ERAS protocol in gynecological surgery and compared outcomes after hysterectomies performed for malignant vs. benign indications.Methods: This prospective cohort study was conducted at the Department of Obstetrics and Gynecology, Örebro University Hospital, Sweden, among 121 consecutive patients undergoing abdominal hysterectomy and salpingo-oophorectomy for malignant (n = 40) or benign (n = 81) indications between 2012 and 2014. Clinical data were prospectively collected and extracted from the patient records and from a specific database. The primary outcomes were LOS and proportion of patients achieving target LOS (2 days).Results: Patients operated for malignant vs. benign disease did not differ significantly in terms of LOS (2 (1-5) vs. 2 (1-11) days; p = 0.505), proportion discharged at target LOS (62 vs. 69%; p = 0.465; OR 0.74, 95% CI 0.3-1.6), complications (2 vs. 7% in primary stay, 8 vs. 11% within 30 days after discharge), re operations (0 vs. 2%), or readmissions (2 vs. 1%).Conclusion: The ERAS protocol may be equally applicable to patients undergoing hysterectomy either for a malignant or for a benign disease.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Reproduktionsmedicin och gynekologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Obstetrics, Gynaecology and Reproductive Medicine (hsv//eng)
Keyword
- ERAS
- Fast-track
- Hysterectomy
- Length of stay
- Perioperative care
- Obstetrik och gynekologi
- Obstetrics and Gynaecology
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database